Helsinn Advanced Synthesis SA

Sales markets: Western Europe | Asia | North America

About us

Helsinn Advanced Synthesis SA develops and manufactures APIs, HPAPIs, and Anticancer compounds for third parties on an exclusive basis. A wide range of reactors allows batch size flexibility with full analytical support. For HPAPI and Anticancers, containment technologies have been engineered for handling of products. Our cGMP facilities in Biasca, Switzerland have been successfully approved by the Swiss and European authorities, US FDA (No 483s) and PMDA.



Read more

Meet us at

18 apr 2018

CPhI Japan 2018

18 - 20 April 2018 Tokyo, Japan Visit us at stand F-02 Book a meeting See our Exhibitor Profile
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA Visit us at stand 749 Book a meeting See our Exhibitor Profile

News about Helsinn Advanced Synthesis SA

Helsinn - Building quality cancer care together

16 Sep 2016

Helsinn - Building quality cancer care together

Helsinn Advanced Synthesis develops and manufactures compounds for clinical and commercial use in several containment classes: Active Pharmaceutical Ingredients (APIs), Advanced Intermediates, High Potency APIs (HPAPIs) and Anticancer compounds. These compounds are manufactured for third parties on an exclusive basis, with a high level of service and with an innovative touch.

Read more

Categories affiliated with Helsinn Advanced Synthesis SA